Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Pacific Biosciences of California Inc (NASDAQ: PACB) closed at $1.33 in the last session, up 2.31% from day before closing price of $1.30. In other words, the price has increased by $2.31 from its previous closing price. On the day, 12.46 million shares were traded.
Ratios:
We take a closer look at PACB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.13 and its Current Ratio is at 12.63. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.32.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when HENRY CHRISTIAN O sold 12,497 shares for $1.41 per share. The transaction valued at 17,583 led to the insider holds 2,225,357 shares of the business.
Van Oene Mark sold 6,486 shares of PACB for $9,126 on Mar 03 ’25. The insider now owns 1,497,695 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Farmer Michele, who serves as the insider of the company, sold 2,973 shares for $1.41 each. As a result, the insider received 4,183 and left with 184,619 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.37 while its Price-to-Book (P/B) ratio in mrq is 0.80.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $5.01, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -20.05%, while the 200-Day Moving Average is calculated to be -24.24%.
Shares Statistics:
A total of 273.86M shares are outstanding, with a floating share count of 243.51M. Insiders hold about 11.08% of the company’s shares, while institutions hold 84.34% stake in the company.
